Join the Carcinoid Syndrome Diarrhea group to help and get support from people like you.
Carcinoid Syndrome Diarrhea News
FDA Approves Xermelo (telotristat ethyl) as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metastatic Neuroendocrine Tumors
The Woodlands, Texas, February 28, 2017 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that the U.S. Food and Drug Administration (FDA) has approved Xermelo (telotristat ethyl) 250 mg ...
Ask a question
To post your own question to this support group, sign in or create an account.